Paclitaxel (Taxol) is one of the most active drugs in the treatment of ovarian and breast cancers. Combination therapy with paclitaxel and 5-fluorouracil (5-FU) exhibits high activity in anthracycline-pretreated breast cancer,
H. Kühnle, MD
Advertisement
Articles by H. Kühnle, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Ultra-Hypofractionation Proves Feasible in Locally Advanced Breast Cancer
2
Tazemetostat Withdrawn From Follicular Lymphoma, Sarcoma Markets
3
GLP-1 Receptor Agonists in Breast Cancer: 5 Key Clinical Takeaways
4
Mezigdomide Regimen Boosts PFS in Relapsed/Refractory Multiple Myeloma
5